(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOLINQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BIOLINQ

ST13

US500000090743811

Class

10

Filing

90743811

Registration

7231354

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

04/30/2025

Trademark type

Combined

Nice classes

10

Filing date

05/30/2021

Registration date

11/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/28/2023

Last transaction

04/30/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/06/2022

First use in commerce

07/06/2022

Drawing code

3

Owner type

03

Owner location

San Diego, CA

Examiner

BIBB, SCOTT

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word biolinq with a continuous path that forms a cross.

Holders and representatives

Holders

B. I. (pessoa física)
Biolinq, Inc.

Representatives

John Paul Oleksiuk Cooley LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Wearable monitors used to measure biometric data for medical use; glucose meters; wearable devicescontinuous glucose sensors for monitoring blood glucose levels for medical purposes

Publications

History of USPTO decisions and trademark events.

37 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/23/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/23/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/23/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/28/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/24/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/21/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/13/2023

IUAF

USE AMENDMENT FILED

05/01/2023

EISU

TEAS STATEMENT OF USE RECEIVED

05/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/14/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/13/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

02/01/2023

CHPB

POST PUBLICATION AMENDMENT - ENTERED

01/23/2023

APET

ASSIGNED TO PETITION STAFF

01/18/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/17/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

12/22/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/22/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/22/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/22/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/22/2022

PUBO

PUBLISHED FOR OPPOSITION

11/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/19/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/24/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/23/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/23/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/28/2022

GNRT

NON-FINAL ACTION E-MAILED

02/28/2022

CNRT

NON-FINAL ACTION WRITTEN

02/28/2022

DOCK

ASSIGNED TO EXAMINER

02/12/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/15/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/15/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/15/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/25/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/24/2021

NWAP

NEW APPLICATION ENTERED

06/02/2021

Continuous trademark protection

Get notified about every new filing that threatens BIOLINQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.